An open-label trial of memantine in treatment-resistant obsessive-compulsive disorder

BACKGROUND: Obsessive-compulsive disorder (OCD) is often refractory to treatment. Glutamatergic neurotransmission modulating agents like memantine, an N-methyl-D-aspartate receptor open channel blocker (antagonist), has been reported to be beneficial in OCD. MATERIALS AND METHODS: Twelve subjects of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Bakhla, Ajay Kumar, Verma, Vijay, Soren, Subhas, Sarkhel, Sujit, Chaudhury, Suprakash
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Medknow Publications & Media Pvt Ltd 2013
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4085808/
https://ncbi.nlm.nih.gov/pubmed/25013317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0972-6748.132930
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller